Fermenta Biotech Ltd

Established in 1951, DIL Limited (earlier known as Duphar-Interfran Limited) is a publicly-listed company that has developed a unique standing in the businesses of pharmaceuticals, biotechnology, environmental solutions and other segments.(Source : 201983 Annual Report Page No: 6)

Pros:
Company has good consistent profit growth of 74.31% over 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 30.43%
Debtor days have improved from 80.50 to 59.29 days.
Cons:
Tax rate seems low
** Remarks:
Some businesses are provided tax benefits to encourage their development

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019
38 44 44 64 98 97 80 121 112 92 81 81
38 39 42 50 59 59 54 77 67 61 57 65
Operating Profit -0 5 2 13 40 38 26 44 45 31 25 16
OPM % -1% 12% 4% 21% 40% 39% 32% 37% 40% 34% 30% 19%
Other Income 1 0 0 4 0 4 3 9 1 1 3 5
Interest 2 2 3 4 2 4 4 5 6 6 5 5
Depreciation 3 3 3 3 3 4 3 3 3 3 4 4
Profit before tax -4 0 -3 11 34 35 22 46 37 23 19 12
Tax % 0% 239% -9% 40% 23% 24% 24% 25% 25% -65% 26% -168%
Net Profit -4 -2 -4 4 19 16 15 32 26 37 13 33
EPS in Rs -4.73 -2.20 -4.38 7.27 20.62 4.33 18.03 34.84 28.25 40.59 14.21 33.99
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
52 67 68 76 119 117 139 142 155 164 302 403 365
42 57 53 57 88 94 112 126 134 152 209 248 249
Operating Profit 11 10 15 19 31 23 27 16 20 12 93 155 116
OPM % 20% 15% 22% 25% 26% 20% 20% 11% 13% 7% 31% 38% 32%
Other Income 2 4 6 23 14 2 2 0 1 3 9 6 11
Interest 1 3 2 1 4 5 5 4 6 10 14 21 21
Depreciation 4 5 4 4 8 9 10 9 8 10 12 12 13
Profit before tax 7 6 15 36 33 10 14 3 7 -6 76 129 92
Tax % 7% 28% 22% 23% 19% 36% 24% 67% 61% -49% 28% 8%
Net Profit 7 6 12 25 22 4 8 0 -1 -11 34 110 109
EPS in Rs 7.19 5.73 11.90 26.55 22.98 3.60 8.14 0.25 0.00 0.00 36.65 120.31 117.04
Dividend Payout % 33% 59% 30% 23% 31% 124% 29% 249% -51% -5% 2% 1%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:19.63%
5 Years:23.73%
3 Years:37.62%
TTM:-7.96%
Compounded Profit Growth
10 Years:34.65%
5 Years:74.31%
3 Years:377.21%
TTM:32.55%
Stock Price CAGR
10 Years:23.61%
5 Years:29.57%
3 Years:45.66%
1 Year:-40.63%
Return on Equity
10 Years:14.59%
5 Years:19.12%
3 Years:30.43%
Last Year:64.55%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Sep 2019
2 2 2 2 2 2 2 2 2 2 2 5 5
Reserves 75 77 85 113 127 125 130 129 128 142 122 228 294
Borrowings 12 18 14 20 37 43 65 71 89 87 173 212 213
24 25 21 38 52 57 63 62 72 80 87 111 120
Total Liabilities 113 123 121 173 218 228 261 264 290 312 385 555 631
40 53 39 46 73 94 87 85 168 172 177 178 195
CWIP 8 4 7 14 13 15 36 65 6 5 4 22 50
Investments 20 18 27 41 18 11 17 18 15 18 10 8 8
46 48 48 72 115 107 120 96 101 116 193 348 377
Total Assets 113 123 121 173 218 228 261 264 290 312 385 555 631

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
10 8 2 -1 39 23 14 15 4 2 59 90
-19 -13 2 -7 -50 -20 -25 -18 -13 7 -101 -97
13 4 -5 16 7 -8 13 1 10 -12 89 12
Net Cash Flow 3 -0 -1 8 -4 -4 2 -2 1 -4 47 6

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 10% 10% 17% 19% 18% 9% 10% 4% 6% 2% 34% 42%
Debtor Days 98 76 64 81 72 79 106 91 101 99 83 59
Inventory Turnover 6.99 8.51 8.89 8.42 7.39 5.00 5.73 6.29 6.24 4.91 6.71 5.81

Recent Announcements

View all announcements

Annual Reports

Credit Ratings